Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Dörschner, , Gülsen,
DOB: 30-JUL-1970 (Age: 55)
Gender: female
Address:
Patbergplatz 571
56068 Koblenz (Germany)
ID: 3549-346619-3 (ECI)
Report
Date: 07-JAN-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Brüderhaus Koblenz
Kardinal-Krementz-Straße 1-5
56068 Koblenz (Germany)
Specimen
Collected: 07-JAN-2018

Chemistry

Test 07-JAN-2018 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 121.4 L 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 104.5 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 44.0 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.5 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters are within or close to normal ranges, with only mildly decreased total cholesterol. LDL and HDL cholesterol, as well as triglycerides, are within normal limits. No significant dyslipidemia is present; the mildly low total cholesterol is not clinically concerning in isolation. No further action required from a laboratory perspective.